News

Articles

CytoReason has announced an expanded collaboration deal with Pfizer to deliver AI for drug discovery and development.

CytoReason Announces Expanded Collaboration Deal with Pfizer

Civica is expanding in the greater Richmond-Petersburg region and investing $27.8 million in a new testing facility. 

Civica to Invest $27.8 Million in New Testing Facility

Novo Nordisk and Microsoft are collaborating to accelerate drug discovery and development using big data and artificial intelligence. 

Novo Nordisk and Microsoft Collaborate to Accelerate Drug Discovery and Development

Ensysce Biosciences and Quotient Sciences are partnering to develop and test Ensysce’s novel opioid designed to prevent abuse and overdose.

Ensysce Biosciences and Quotient Sciences Announce Partnership 

EMA has recommended approval of Enjaymo for the treatment of hemolytic anemia in adult patients with cold agglutinin disease.

EMA Recommends Approval of Enjaymo

 Washington Editor, jillwechsler7@gmail.com.

The White House hopes to expand US modern biotech manufacturing and reduce reliance on foreign sources of bioindustrial materials. 

Advanced Biopharma Manufacturing Key to White House Cancer Moonshot

WHO has awarded prequalification to GSK’s Mosquirix, an approved malaria vaccine.

WHO Grants Prequalification to GSK’s Malaria Vaccine

Salipro has been granted patents in the United States and China for its proprietary technology to enable the development of therapeutics against challenging drug targets.

Salipro Biotech Obtains Patents in US and China for Direct Extraction of Membrane Proteins and Library Generation

Charles River Laboratories and Cure AP-4 will collaborate on gene therapy manufacturing for AP-4 hereditary spastic paraplegia.

Charles River and Cure AP-4 Announce Manufacturing Collaboration

In partnership with the University of Pittsburgh, ElevateBio will open its next manufacturing center in the city.

Industry News